A Prospective Randomized Trial of Two Different Prostate Biopsy Schemes
Prostate Cancer, Local Anesthesia, Prostate-Specific Antigen/Blood
About this trial
This is an interventional diagnostic trial for Prostate Cancer focused on measuring Prostatic Neoplasms, Biopsy, Anesthesia, Detection
Eligibility Criteria
Inclusion Criteria:
- Formal indication to prostate biopsy: PSA elevation, positive digital rectal examination of prostate, prostate cancer active surveillance protocols.
- Patients signing the consent therm agreeing to participate in the trial
- Exclusive local anesthesia prostate biopsy.
- Exclusive transrectal ultrasound guided prostate biopsy.
Exclusion Criteria:
- Transperineal ultrasound guided prostate biopsy
- Magnetic resonance cognitive fusion biopsy.
- Previous treatment with radiation therapy or brachytherapy.
- Previous treatment with focal therapy
- Previous androgen deprivation therapy
Sites / Locations
- Hospital Brigadeiro UGA V-SP
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
20 core-biopsy fragments
Base and apex local anesthesia
Patients submitted to experimental intervention (extended sextant biopsy with 20 cores) compared to current standard biopsy protocol (extended sextant biopsy with 12 cores) guided by transrectal ultrasound.
Patients submitted to experimental intervention in prostate-biopsy anesthetic protocol (prostate base and prostate apex bilateral local anesthetic injection) compared to participants submitted to current standard anesthetic protocol in institution (prostate base bilateral local anesthesia) guided by transrectal ultrasound. guided by transrectal ultrasound.